179 related articles for article (PubMed ID: 8525285)
1. The chemotherapy of onchocerciasis. XIX: The clinical and laboratory tolerance of high dose ivermectin.
Awadzi K; Opoku NO; Addy ET; Quartey BT
Trop Med Parasitol; 1995 Jun; 46(2):131-7. PubMed ID: 8525285
[TBL] [Abstract][Full Text] [Related]
2. The co-administration of ivermectin and albendazole--safety, pharmacokinetics and efficacy against Onchocerca volvulus.
Awadzi K; Edwards G; Duke BO; Opoku NO; Attah SK; Addy ET; Ardrey AE; Quartey BT
Ann Trop Med Parasitol; 2003 Mar; 97(2):165-78. PubMed ID: 12803872
[TBL] [Abstract][Full Text] [Related]
3. The chemotherapy of onchocerciasis XX: ivermectin in combination with albendazole.
Awadzi K; Addy ET; Opoku NO; Plenge-Bönig A; Büttner DW
Trop Med Parasitol; 1995 Dec; 46(4):213-20. PubMed ID: 8826100
[TBL] [Abstract][Full Text] [Related]
4. The chemotherapy of onchocerciasis X. An assessment of four single dose treatment regimes of MK-933 (ivermectin) in human onchocerciasis.
Awadzi K; Dadzie KY; Shulz-Key H; Haddock DR; Gilles HM; Aziz MA
Ann Trop Med Parasitol; 1985 Feb; 79(1):63-78. PubMed ID: 3838638
[TBL] [Abstract][Full Text] [Related]
5. The safety, tolerability and pharmacokinetics of levamisole alone, levamisole plus ivermectin, and levamisole plus albendazole, and their efficacy against Onchocerca volvulus.
Awadzi K; Edwards G; Opoku NO; Ardrey AE; Favager S; Addy ET; Attah SK; Yamuah LK; Quartey BT
Ann Trop Med Parasitol; 2004 Sep; 98(6):595-614. PubMed ID: 15324466
[TBL] [Abstract][Full Text] [Related]
6. Evidence for macrofilaricidal activity of ivermectin against female Onchocerca volvulus: further analysis of a clinical trial in the Republic of Cameroon indicating two distinct killing mechanisms.
Duke BO
Parasitology; 2005 Apr; 130(Pt 4):447-53. PubMed ID: 15830819
[TBL] [Abstract][Full Text] [Related]
7. Chemokines in onchocerciasis patients after a single dose of ivermectin.
Fendt J; Hamm DM; Banla M; Schulz-Key H; Wolf H; Helling-Giese G; Heuschkel C; Soboslay PT
Clin Exp Immunol; 2005 Nov; 142(2):318-26. PubMed ID: 16232219
[TBL] [Abstract][Full Text] [Related]
8. Onchocerca volvulus and O. lienalis: the microfilaricidal activity of moxidectin compared with that of ivermectin in vitro and in vivo.
Tagboto SK; Townson S
Ann Trop Med Parasitol; 1996 Oct; 90(5):497-505. PubMed ID: 8915126
[TBL] [Abstract][Full Text] [Related]
9. The chemotherapy of onchocerciasis. XIII. Studies with ivermectin in onchocerciasis patients in northern Ghana, a region with long lasting vector control.
Awadzi K; Dadzie KY; Kläger S; Gilles HM
Trop Med Parasitol; 1989 Sep; 40(3):361-6. PubMed ID: 2694315
[TBL] [Abstract][Full Text] [Related]
10. Eosinophil sequestration and activation are associated with the onset and severity of systemic adverse reactions following the treatment of onchocerciasis with ivermectin.
Cooper PJ; Awadzi K; Ottesen EA; Remick D; Nutman TB
J Infect Dis; 1999 Mar; 179(3):738-42. PubMed ID: 9952390
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy of onchocerciasis with high doses of diethylcarbamazine or a single dose of ivermectin: microfilaria levels and side effects.
Albiez EJ; Newland HS; White AT; Kaiser A; Greene BM; Taylor HR; Büttner DW
Trop Med Parasitol; 1988 Mar; 39(1):19-24. PubMed ID: 3291074
[TBL] [Abstract][Full Text] [Related]
12. Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection.
Gardon J; Gardon-Wendel N; Demanga-Ngangue ; Kamgno J; Chippaux JP; Boussinesq M
Lancet; 1997 Jul; 350(9070):18-22. PubMed ID: 9217715
[TBL] [Abstract][Full Text] [Related]
13. The safety and efficacy of amocarzine in African onchocerciasis and the influence of ivermectin on the clinical and parasitological response to treatment.
Awadzi K; Opoku NO; Attah SK; Addy ET; Duke BO; Nyame PK; Kshirsagar NA
Ann Trop Med Parasitol; 1997 Apr; 91(3):281-96. PubMed ID: 9229021
[TBL] [Abstract][Full Text] [Related]
14. The effects of high-dose ivermectin regimens on Onchocerca volvulus in onchocerciasis patients.
Awadzi K; Attah SK; Addy ET; Opoku NO; Quartey BT
Trans R Soc Trop Med Hyg; 1999; 93(2):189-94. PubMed ID: 10450448
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerance of ivermectin in human onchocerciasis.
Aziz MA; Diallo S; Diop IM; Lariviere M; Porta M
Lancet; 1982 Jul; 2(8291):171-3. PubMed ID: 6123884
[TBL] [Abstract][Full Text] [Related]
16. Emergence of Onchocerca volvulus microfilariae from skin snips before and after treatment of patients with ivermectin.
Mössinger J; Schulz-Key H; Dietz K
Trop Med Parasitol; 1988 Dec; 39(4):313-6. PubMed ID: 3067322
[TBL] [Abstract][Full Text] [Related]
17. Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis.
Greene BM; Taylor HR; Cupp EW; Murphy RP; White AT; Aziz MA; Schulz-Key H; D'Anna SA; Newland HS; Goldschmidt LP
N Engl J Med; 1985 Jul; 313(3):133-8. PubMed ID: 3892293
[TBL] [Abstract][Full Text] [Related]
18. Single dose moxidectin versus ivermectin for Onchocerca volvulus infection in Ghana, Liberia, and the Democratic Republic of the Congo: a randomised, controlled, double-blind phase 3 trial.
Opoku NO; Bakajika DK; Kanza EM; Howard H; Mambandu GL; Nyathirombo A; Nigo MM; Kasonia K; Masembe SL; Mumbere M; Kataliko K; Larbelee JP; Kpawor M; Bolay KM; Bolay F; Asare S; Attah SK; Olipoh G; Vaillant M; Halleux CM; Kuesel AC
Lancet; 2018 Oct; 392(10154):1207-1216. PubMed ID: 29361335
[TBL] [Abstract][Full Text] [Related]
19. Adverse systemic reactions to treatment of onchocerciasis with ivermectin at normal and high doses given annually or three-monthly.
Kamgno J; Gardon J; Gardon-Wendel N; Demanga-Ngangue ; Duke BO; Boussinesq M
Trans R Soc Trop Med Hyg; 2004 Aug; 98(8):496-504. PubMed ID: 15186939
[TBL] [Abstract][Full Text] [Related]
20. Treatment of onchocerciasis. The ocular effects of ivermectin and diethylcarbamazine.
Taylor HR; Murphy RP; Newland HS; White AT; D'Anna SA; Keyvan-Larijani E; Aziz MA; Cupp EW; Greene BM
Arch Ophthalmol; 1986 Jun; 104(6):863-70. PubMed ID: 3521559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
